The ACDA weighs in on the FDA proposed rule for Gluten-Free Labeling

With the recent close of the comment period (3 October) to the Food and Drug Administration (FDA), with regards to the FDA Proposal for a Gluten-Free Labeling Law, The American Celiac Disease Alliance, a national celiac support organization located in Alexandria, VA weighed in with their comments via a letter from Andrea Levario, J.D., Executive Director, dated 3 October 2011. ACDA was instrumental in bringing forth the passage of the Food Allergen Labeling and Consumer Protection Act (FALCPA) and with the advancement of this first ever rulemaking on gluten-free labeling in the US.

The FDA is expected to review all comments submitted, including those solicited from the general public during the “comment” period, and are hoping for a July 2012  implementation.

To read the very detailed and informative letter from ACDA to the FDA click here: http://www.celiac.org/images/cc/acda.pdf

Other useful links regarding the FDA proposal and the standards being considered:

http://www.fda.gov/Food/LabelingNutrition/FoodLabelingGuidanceRegulatoryInformation/Topic-SpecificLabelingInformation/ucm265309.htm

http://1in133.org/proposal/resources/assessment/

http://americanceliac.org/wp-content/uploads/2011/08/ACDA-FDA-8-2-11.pdf

Did you find this post useful? How do you feel about the proposed 20 ppm threshold being considered safe for Celiacs?